The Good, The Bad And The Ugly: Johnson & Johnson [View article]
If you did your research on recently approved J&J drugs which could have potential blockbuster sales, understood the product leadership diversity this company has which protects J&J against failure in any one segment of its business, and understood how J&J is heavily invested in new cancer treatment drugs, you would not have been preaching about product recalls which are now old news. Credorules
Johnson & Johnson's Governance Issue [View article]
If you were not biased, you could write about all of the new blockbuster drugs and medical devices J&J has recently brought to market, or are awaiting final testing stage approval. You might even note that J&J has a new CEO who should be given his chance at corporate governance.
The Good, The Bad And The Ugly: Johnson & Johnson [View article]
The Good, The Bad And The Ugly: Johnson & Johnson [View article]
Credorules
Johnson & Johnson's Governance Issue [View article]
If you were not biased, you could write about all of the new blockbuster drugs and medical devices J&J has recently brought to market, or are awaiting final testing stage approval.
You might even note that J&J has a new CEO who should be given his chance at corporate governance.